[1] |
李青,程继义,王振声,等. 肾癌369例临床分析[J]. 中华泌尿外科杂志, 2001, 22(8): 496-498.
|
[2] |
Godley PA, Stinchcombe TE. Renal cell carcinoma[J]. Curr Opin Oncol, 1999, 11(3): 213-217.
|
[3] |
Paul R, Mordhorst J, Busch R, et al. Adrenal sparing surgery during radical nephrectomy in patients with renal cell cancer: a new algorithm[J]. J Urol, 2001, 166(1): 59-62.
|
[4] |
Daugherty M, Bratslavsky G. Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤4 cm): an analysis of the SEER database[J]. Urol Oncol, 2014, 32(5): 549-554.
|
[5] |
Clark PE, Schover LR, Uzzo RG, et al. Quality of life and psychological adaptation after surgical treatment for localized renal cell carcinoma: impact of the amount of remaining renal tissue[J]. Urology, 2001, 57(2): 252-256.
|
[6] |
Lau WK, Blute ML, Weaver AL, et al. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney[J]. Mayo Clin Proc, 2000, 75(12): 1236-1242.
|
[7] |
Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma[J]. N Engl J Med, 2016, 374(2): 135-145.
|
[8] |
Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90.
|
[9] |
刘宁,甘卫东,郭宏骞. 2016年WHO肾肿瘤分类的认识[J/CD]. 中华腔镜泌尿外科杂志:电子版, 2016, 10(5): 1-6.
|
[10] |
Moch H, Cubilla AL, Humphrey PA, et al. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours[J]. Eur Urol, 2016, 70(1): 93-105.
|
[11] |
Russo P, Huang W. The medical and oncological rationale for partial nephrectomy for the treatment of T1 renal cortical tumors[J]. Urol Clin North Am, 2008, 35(4): 635-643.
|
[12] |
Weight CJ, Larson BT, Gao T, et al. Elective partial nephrectomy in patients with clinical T1b renal tumors is associated with improved overall survival[J]. Urology, 2010, 76(3): 631-637.
|
[13] |
Kim JM, Song PH, Kim HT, et al. Comparison of Partial and Radical Nephrectomy for pT1b Renal Cell Carcinoma[J]. Korean J Urol, 2010, 51(9): 596-600.
|
[14] |
Deklaj T, Lifshitz DA, Shikanov SA, et al. Laparoscopic radical versus laparoscopic partial nephrectomy for clinical T1bN0M0 renal tumors: comparison of perioperative, pathological, and functional outcomes[J]. J Endourol, 2010, 24(10): 1603-1607.
|
[15] |
Van Poppel H, Da Pozzo L, Albrecht W, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma[J]. Eur Urol, 2011, 59(4): 543-552.
|
[16] |
黄翼然. 从肾脏解剖和肾癌病理特征谈保留肾单位手术[J]. 临床泌尿外科杂志, 2016, 31(3): 195-197.
|
[17] |
Azhar RA, de Castro Abreu AL, Broxham E, et al. Histological analysis of the kidney tumor-parenchyma interface[J]. J Urol, 2015, 193(2): 415-422.
|
[18] |
Stevens LA, Levey AS. Measurement of kidney function[J]. Med Clin North Am, 2005, 89(3): 457-473.
|
[19] |
Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate[J]. Ann Intern Med, 2009, 150(9): 604-612.
|
[20] |
Madero M, Sarnak MJ, Stevens LA. Serum cystatin C as a marker of glomerular filtration rate[J]. Curr Opin Nephrol Hypertens, 2006, 15(6): 610-616.
|
[21] |
Akbari A, Lepage N, Keely E, et al. Cystatin-C and beta trace protein as markers of renal function in pregnancy[J]. BJOG, 2005, 112(5): 575-578.
|
[22] |
赖玮婧,刘芳,付平. 慢性肾脏病评估及管理临床实践指南解读——从K/DOQI到KDIGO[J]. 中国实用内科杂志, 2013, 33(6): 448-453.
|
[23] |
Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report[J]. Kidney Int, 2011, 80(1): 17-28.
|
[24] |
Donadio C, Lucchesi A, Ardini M, et al. Cystatin C, beta 2-microglobulin, and retinol-binding protein as indicators of glomerular filtration rate: comparison with plasma creatinine[J]. J Pharm Biomed Anal, 2001, 24(5-6): 835-842.
|